✦ LIBER ✦

Comparison of131I whole-body imaging,131I SPECT/CT, and18F-FDG PET/CT in the detection of metastatic thyroid cancer

✍ Scribed by Jong-Ryool Oh; Byung-Hyun Byun; Sun-Pyo Hong; Ari Chong; Jahae Kim; Su-Woong Yoo; Sae-Ryung Kang; Dong-Yeon Kim; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min

Publisher: Springer
Year: 2011
Tongue: English
Weight: 613 KB
Volume: 38
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-011-1809-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of whole-body18F-FDG PET,99mT

Comparison of whole-body18F-FDG PET,99mTc-MIBI SPET, and post-therapeutic131I-Na scintigraphy in the detection of metastatic thyroid cancer

✍ Masahiro Iwata; Kanji Kasagi; Takashi Misaki; Keiichi Matsumoto; Yasuhiro Iida; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 381 KB

The clinical impact of18F-FDG PET in pap

The clinical impact of18F-FDG PET in papillary thyroid carcinoma with a negative131I whole body scan: A single-center study of 108 patients

✍ Mi-Yeon Choi; June-Key Chung; Ho-Yeong Lee; Young So; Do Joon Park; Jae Min Jeon 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 859 KB

Detection of bone metastases in non-smal

Detection of bone metastases in non-small cell lung cancer patients: Comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy

✍ Daisuke Takenaka; Yoshiharu Ohno; Keiko Matsumoto; Nobukazu Aoyama; Yumiko Onish 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

## Abstract ## Purpose To prospectively compare the capability for bone metastasis assessment of whole‐body diffusion‐weighted imaging (DWI), magnetic resonance imaging (MRI) without and with DWI, [^18^F] fluoro‐2‐D‐glucose positron emission tomography with computed tomography (FDG‐PET/CT) and bon

Whole-body MR imaging with the use of pa

Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT

✍ Jyoti Kumar; Ashu Seith; Atin Kumar; Raju Sharma; Sameer Bakhshi; Rakesh Kumar; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 436 KB

18F-FDG PET/CT and 3.0-T whole-body MRI

18F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study

✍ Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 606 KB

Immunoscintigraphy with 131I-labelled mo

Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients

✍ D. Pectasides; K. Pateniotis; L. Tzimis; X. Trapalli; P. Natsis; P. Arapantoni; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 514 KB

3'I-labelled HMFGl or HMFGl F(ab')2 monoclonal antibody (MAb) was administered intraperitoneally to I S patients with epithelial ovarian cancer who had completed chemotherapy and were in complete or good partial remission. Each patient received 2-3 mCi. Patients were scanned immediately after and un